HEADER OXIDOREDUCTASE 31-MAR-22 7ZEJ TITLE CRYSTAL STRUCTURE OF THE HUMAN MGC45594 GENE PRODUCT IN COMPLEX WITH TITLE 2 CELECOXIB. COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROSTAGLANDIN REDUCTASE 3; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PRG-3,ZINC-BINDING ALCOHOL DEHYDROGENASE DOMAIN-CONTAINING COMPND 5 PROTEIN 2; COMPND 6 EC: 1.3.1.48; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ZADH2, PTGR3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ALKENAL REDUCTASES, PROSTAGLANDIN REDUCTASES, PHASE 1 XENOBIOTIC KEYWDS 2 METABOLISM, REACTIVE OXYGEN SPECIES, LIPID PEROXIDATION, KEYWDS 3 POLYUNSATURATED FATTY ACID, INFLAMMATION, LIPID MEDIATOR METABOLISM, KEYWDS 4 STRUCTURAL GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, KEYWDS 5 OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR N.SHAFQAT,W.W.YUE,L.KOEKEMOER,F.NIESEN,E.UGOCHUKWU,M.VOLLMAR, AUTHOR 2 J.WEIGELT,T.KROJER,A.PIKE,A.CHAIKAUD,F.VON DELFT,C.ARROWSMITH, AUTHOR 3 C.BOUNTRA,A.EDWARDS,U.OPPERMAN,STRUCTURAL GENOMICS CONSORTIUM (SGC) REVDAT 2 31-JAN-24 7ZEJ 1 REMARK REVDAT 1 04-MAY-22 7ZEJ 0 JRNL AUTH N.SHAFQAT,S.G.DAKIN,F.M.ESTRADA,F.H.NIESEN,G.WELLS,C.YAPP, JRNL AUTH 2 M.K.TROUMPRA,D.BROTHERTON,S.PORTE,J.MESA,E.YAKOVTSEVA, JRNL AUTH 3 J.FARRES,X.PARES,T.LIU,R.ALTMAN,A.CARR,L.KOEKEMOER,F.NIESEN, JRNL AUTH 4 W.W.YUE,U.OPPERMAN JRNL TITL HUMAN PROSTAGLANDIN/ALKENAL REDUCTASES: SUBSTRATE JRNL TITL 2 SPECIFICITIES, INHIBITOR PROFILES, STRUCTURAL INSIGHTS AND JRNL TITL 3 SUBCELLULAR LOCALIZATION SUGGEST PROTECTIVE ROLES IN JRNL TITL 4 INFLAMMATORY AND OXIDATIVE STRESS CONDITIONS. JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.79 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.79 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 16.76 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 85.8 REMARK 3 NUMBER OF REFLECTIONS : 55934 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.095 REMARK 3 FREE R VALUE TEST SET COUNT : 1731 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.79 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.84 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3164 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 67.93 REMARK 3 BIN R VALUE (WORKING SET) : 0.3130 REMARK 3 BIN FREE R VALUE SET COUNT : 100 REMARK 3 BIN FREE R VALUE : 0.3180 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5074 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 148 REMARK 3 SOLVENT ATOMS : 169 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.31 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.46900 REMARK 3 B22 (A**2) : 4.79700 REMARK 3 B33 (A**2) : -3.05000 REMARK 3 B12 (A**2) : -1.73500 REMARK 3 B13 (A**2) : 0.48800 REMARK 3 B23 (A**2) : 0.20200 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.143 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.140 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.134 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.935 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.963 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.937 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5342 ; 0.008 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 5102 ; 0.001 ; 0.015 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7276 ; 1.580 ; 1.661 REMARK 3 BOND ANGLES OTHERS (DEGREES): 11769 ; 1.319 ; 1.579 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 681 ; 6.995 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 201 ;36.341 ;22.488 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 864 ;13.754 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;19.634 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 698 ; 0.070 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5959 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1099 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 939 ; 0.199 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 93 ; 0.207 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2597 ; 0.158 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 215 ; 0.149 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2727 ; 1.911 ; 2.724 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2726 ; 1.911 ; 2.723 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3407 ; 2.909 ; 4.076 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 3408 ; 2.908 ; 4.077 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2615 ; 2.540 ; 3.060 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2616 ; 2.540 ; 3.062 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3869 ; 3.988 ; 4.490 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3870 ; 3.988 ; 4.492 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK BULK SOLVENT REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THEIR REMARK 3 RIDING POSITIONS REMARK 4 REMARK 4 7ZEJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-APR-22. REMARK 100 THE DEPOSITION ID IS D_1292122060. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-JAN-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0-8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9763 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 101296 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.790 REMARK 200 RESOLUTION RANGE LOW (A) : 16.760 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 85.8 REMARK 200 DATA REDUNDANCY : 1.800 REMARK 200 R MERGE (I) : 0.05200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.79 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.89 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.22600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2C0C REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.07 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.5M NA MALONATE PH 7.0, 0.25W/V REMARK 280 JEFFAMINE ED 2001 PH 7.0 HEPES PH 8.0, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6990 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26290 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 -46.83000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS B 362 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HH21 ARG A 61 OE2 GLU A 359 1.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 549 O HOH B 551 1455 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 33 146.28 -171.42 REMARK 500 PRO A 79 12.16 -65.31 REMARK 500 PHE A 262 62.62 -153.42 REMARK 500 CYS A 321 73.32 -116.99 REMARK 500 PHE B 262 59.55 -150.50 REMARK 500 CYS B 321 74.60 -118.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2C0C RELATED DB: PDB REMARK 900 MGC45594 GENE PRODUCT REMARK 900 RELATED ID: 2WEK RELATED DB: PDB REMARK 900 MGC45594 GENE PRODUCT IN COMPLEX WITH DICLOFENAC REMARK 900 RELATED ID: 2X1H RELATED DB: PDB REMARK 900 MGC45594 GENE PRODUCT IN COMPLEX WITH RALOXIFENE REMARK 900 RELATED ID: 2X7H RELATED DB: PDB REMARK 900 MGC45594 GENE PRODUCT IN COMPLEX WITH FENOPROFEN REMARK 900 RELATED ID: MGC45594A RELATED DB: TARGETTRACK DBREF 7ZEJ A 24 362 UNP Q8N4Q0 PTGR3_HUMAN 33 371 DBREF 7ZEJ B 24 362 UNP Q8N4Q0 PTGR3_HUMAN 33 371 SEQADV 7ZEJ SER A 22 UNP Q8N4Q0 EXPRESSION TAG SEQADV 7ZEJ MET A 23 UNP Q8N4Q0 EXPRESSION TAG SEQADV 7ZEJ SER B 22 UNP Q8N4Q0 EXPRESSION TAG SEQADV 7ZEJ MET B 23 UNP Q8N4Q0 EXPRESSION TAG SEQRES 1 A 341 SER MET MET GLN LYS LEU VAL VAL THR ARG LEU SER PRO SEQRES 2 A 341 ASN PHE ARG GLU ALA VAL THR LEU SER ARG ASP CYS PRO SEQRES 3 A 341 VAL PRO LEU PRO GLY ASP GLY ASP LEU LEU VAL ARG ASN SEQRES 4 A 341 ARG PHE VAL GLY VAL ASN ALA SER ASP ILE ASN TYR SER SEQRES 5 A 341 ALA GLY ARG TYR ASP PRO SER VAL LYS PRO PRO PHE ASP SEQRES 6 A 341 ILE GLY PHE GLU GLY ILE GLY GLU VAL VAL ALA LEU GLY SEQRES 7 A 341 LEU SER ALA SER ALA ARG TYR THR VAL GLY GLN ALA VAL SEQRES 8 A 341 ALA TYR MET ALA PRO GLY SER PHE ALA GLU TYR THR VAL SEQRES 9 A 341 VAL PRO ALA SER ILE ALA THR PRO VAL PRO SER VAL LYS SEQRES 10 A 341 PRO GLU TYR LEU THR LEU LEU VAL SER GLY THR THR ALA SEQRES 11 A 341 TYR ILE SER LEU LYS GLU LEU GLY GLY LEU SER GLU GLY SEQRES 12 A 341 LYS LYS VAL LEU VAL THR ALA ALA ALA GLY GLY THR GLY SEQRES 13 A 341 GLN PHE ALA MET GLN LEU SER LYS LYS ALA LYS CYS HIS SEQRES 14 A 341 VAL ILE GLY THR CYS SER SER ASP GLU LYS SER ALA PHE SEQRES 15 A 341 LEU LYS SER LEU GLY CYS ASP ARG PRO ILE ASN TYR LYS SEQRES 16 A 341 THR GLU PRO VAL GLY THR VAL LEU LYS GLN GLU TYR PRO SEQRES 17 A 341 GLU GLY VAL ASP VAL VAL TYR GLU SER VAL GLY GLY ALA SEQRES 18 A 341 MET PHE ASP LEU ALA VAL ASP ALA LEU ALA THR LYS GLY SEQRES 19 A 341 ARG LEU ILE VAL ILE GLY PHE ILE SER GLY TYR GLN THR SEQRES 20 A 341 PRO THR GLY LEU SER PRO VAL LYS ALA GLY THR LEU PRO SEQRES 21 A 341 ALA LYS LEU LEU LYS LYS SER ALA SER VAL GLN GLY PHE SEQRES 22 A 341 PHE LEU ASN HIS TYR LEU SER LYS TYR GLN ALA ALA MET SEQRES 23 A 341 SER HIS LEU LEU GLU MET CYS VAL SER GLY ASP LEU VAL SEQRES 24 A 341 CYS GLU VAL ASP LEU GLY ASP LEU SER PRO GLU GLY ARG SEQRES 25 A 341 PHE THR GLY LEU GLU SER ILE PHE ARG ALA VAL ASN TYR SEQRES 26 A 341 MET TYR MET GLY LYS ASN THR GLY LYS ILE VAL VAL GLU SEQRES 27 A 341 LEU PRO HIS SEQRES 1 B 341 SER MET MET GLN LYS LEU VAL VAL THR ARG LEU SER PRO SEQRES 2 B 341 ASN PHE ARG GLU ALA VAL THR LEU SER ARG ASP CYS PRO SEQRES 3 B 341 VAL PRO LEU PRO GLY ASP GLY ASP LEU LEU VAL ARG ASN SEQRES 4 B 341 ARG PHE VAL GLY VAL ASN ALA SER ASP ILE ASN TYR SER SEQRES 5 B 341 ALA GLY ARG TYR ASP PRO SER VAL LYS PRO PRO PHE ASP SEQRES 6 B 341 ILE GLY PHE GLU GLY ILE GLY GLU VAL VAL ALA LEU GLY SEQRES 7 B 341 LEU SER ALA SER ALA ARG TYR THR VAL GLY GLN ALA VAL SEQRES 8 B 341 ALA TYR MET ALA PRO GLY SER PHE ALA GLU TYR THR VAL SEQRES 9 B 341 VAL PRO ALA SER ILE ALA THR PRO VAL PRO SER VAL LYS SEQRES 10 B 341 PRO GLU TYR LEU THR LEU LEU VAL SER GLY THR THR ALA SEQRES 11 B 341 TYR ILE SER LEU LYS GLU LEU GLY GLY LEU SER GLU GLY SEQRES 12 B 341 LYS LYS VAL LEU VAL THR ALA ALA ALA GLY GLY THR GLY SEQRES 13 B 341 GLN PHE ALA MET GLN LEU SER LYS LYS ALA LYS CYS HIS SEQRES 14 B 341 VAL ILE GLY THR CYS SER SER ASP GLU LYS SER ALA PHE SEQRES 15 B 341 LEU LYS SER LEU GLY CYS ASP ARG PRO ILE ASN TYR LYS SEQRES 16 B 341 THR GLU PRO VAL GLY THR VAL LEU LYS GLN GLU TYR PRO SEQRES 17 B 341 GLU GLY VAL ASP VAL VAL TYR GLU SER VAL GLY GLY ALA SEQRES 18 B 341 MET PHE ASP LEU ALA VAL ASP ALA LEU ALA THR LYS GLY SEQRES 19 B 341 ARG LEU ILE VAL ILE GLY PHE ILE SER GLY TYR GLN THR SEQRES 20 B 341 PRO THR GLY LEU SER PRO VAL LYS ALA GLY THR LEU PRO SEQRES 21 B 341 ALA LYS LEU LEU LYS LYS SER ALA SER VAL GLN GLY PHE SEQRES 22 B 341 PHE LEU ASN HIS TYR LEU SER LYS TYR GLN ALA ALA MET SEQRES 23 B 341 SER HIS LEU LEU GLU MET CYS VAL SER GLY ASP LEU VAL SEQRES 24 B 341 CYS GLU VAL ASP LEU GLY ASP LEU SER PRO GLU GLY ARG SEQRES 25 B 341 PHE THR GLY LEU GLU SER ILE PHE ARG ALA VAL ASN TYR SEQRES 26 B 341 MET TYR MET GLY LYS ASN THR GLY LYS ILE VAL VAL GLU SEQRES 27 B 341 LEU PRO HIS HET NAP A 401 73 HET CEL A 402 40 HET NAP B 401 73 HET CEL B 402 40 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM CEL 4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1- HETNAM 2 CEL YL]BENZENESULFONAMIDE HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE HETSYN CEL CELECOXIB FORMUL 3 NAP 2(C21 H28 N7 O17 P3) FORMUL 4 CEL 2(C17 H14 F3 N3 O2 S) FORMUL 7 HOH *169(H2 O) HELIX 1 AA1 ASN A 35 ALA A 39 1 5 HELIX 2 AA2 SER A 68 ALA A 74 1 7 HELIX 3 AA3 LEU A 100 ARG A 105 5 6 HELIX 4 AA4 SER A 129 ALA A 131 5 3 HELIX 5 AA5 LYS A 138 LEU A 144 1 7 HELIX 6 AA6 VAL A 146 GLY A 159 1 14 HELIX 7 AA7 THR A 176 ALA A 187 1 12 HELIX 8 AA8 SER A 197 LEU A 207 1 11 HELIX 9 AA9 PRO A 219 TYR A 228 1 10 HELIX 10 AB1 GLY A 241 ALA A 250 1 10 HELIX 11 AB2 PHE A 262 TYR A 266 5 5 HELIX 12 AB3 THR A 279 SER A 288 1 10 HELIX 13 AB4 PHE A 295 SER A 301 5 7 HELIX 14 AB5 LYS A 302 SER A 316 1 15 HELIX 15 AB6 GLY A 336 GLU A 338 5 3 HELIX 16 AB7 SER A 339 MET A 349 1 11 HELIX 17 AB8 ASN B 35 ALA B 39 1 5 HELIX 18 AB9 SER B 68 ALA B 74 1 7 HELIX 19 AC1 LEU B 100 ARG B 105 5 6 HELIX 20 AC2 SER B 129 ALA B 131 5 3 HELIX 21 AC3 LYS B 138 THR B 143 1 6 HELIX 22 AC4 VAL B 146 GLY B 159 1 14 HELIX 23 AC5 THR B 176 ALA B 187 1 12 HELIX 24 AC6 SER B 197 LEU B 207 1 11 HELIX 25 AC7 PRO B 219 TYR B 228 1 10 HELIX 26 AC8 GLY B 240 ALA B 250 1 11 HELIX 27 AC9 PHE B 262 TYR B 266 5 5 HELIX 28 AD1 THR B 279 SER B 288 1 10 HELIX 29 AD2 PHE B 295 SER B 301 5 7 HELIX 30 AD3 LYS B 302 SER B 316 1 15 HELIX 31 AD4 GLU B 338 MET B 349 1 12 SHEET 1 AA1 2 MET A 23 VAL A 29 0 SHEET 2 AA1 2 VAL A 40 PRO A 47 -1 O THR A 41 N VAL A 28 SHEET 1 AA2 5 TYR A 123 PRO A 127 0 SHEET 2 AA2 5 ASP A 55 GLY A 64 -1 N LEU A 56 O VAL A 126 SHEET 3 AA2 5 GLU A 90 LEU A 98 -1 O ILE A 92 N ARG A 61 SHEET 4 AA2 5 ALA A 111 MET A 115 -1 O VAL A 112 N GLY A 93 SHEET 5 AA2 5 THR A 132 PRO A 133 -1 O THR A 132 N ALA A 113 SHEET 1 AA3 4 TYR A 123 PRO A 127 0 SHEET 2 AA3 4 ASP A 55 GLY A 64 -1 N LEU A 56 O VAL A 126 SHEET 3 AA3 4 LYS A 355 GLU A 359 -1 O VAL A 358 N VAL A 63 SHEET 4 AA3 4 VAL A 323 ASP A 324 1 N ASP A 324 O LYS A 355 SHEET 1 AA4 6 ARG A 211 ASN A 214 0 SHEET 2 AA4 6 HIS A 190 CYS A 195 1 N GLY A 193 O ILE A 213 SHEET 3 AA4 6 LYS A 166 VAL A 169 1 N VAL A 167 O ILE A 192 SHEET 4 AA4 6 VAL A 232 GLU A 237 1 O TYR A 236 N LEU A 168 SHEET 5 AA4 6 LEU A 251 VAL A 259 1 O ILE A 258 N VAL A 235 SHEET 6 AA4 6 SER A 290 GLY A 293 1 O SER A 290 N LEU A 257 SHEET 1 AA5 2 MET B 23 VAL B 29 0 SHEET 2 AA5 2 VAL B 40 PRO B 47 -1 O THR B 41 N VAL B 28 SHEET 1 AA6 5 TYR B 123 PRO B 127 0 SHEET 2 AA6 5 ASP B 55 GLY B 64 -1 N LEU B 56 O VAL B 126 SHEET 3 AA6 5 GLU B 90 LEU B 98 -1 O GLU B 94 N ARG B 59 SHEET 4 AA6 5 ALA B 111 MET B 115 -1 O VAL B 112 N GLY B 93 SHEET 5 AA6 5 THR B 132 PRO B 133 -1 O THR B 132 N ALA B 113 SHEET 1 AA7 4 TYR B 123 PRO B 127 0 SHEET 2 AA7 4 ASP B 55 GLY B 64 -1 N LEU B 56 O VAL B 126 SHEET 3 AA7 4 LYS B 355 GLU B 359 -1 O VAL B 358 N VAL B 63 SHEET 4 AA7 4 VAL B 323 ASP B 324 1 N ASP B 324 O LYS B 355 SHEET 1 AA8 6 ARG B 211 ASN B 214 0 SHEET 2 AA8 6 HIS B 190 CYS B 195 1 N GLY B 193 O ILE B 213 SHEET 3 AA8 6 LYS B 166 VAL B 169 1 N VAL B 167 O ILE B 192 SHEET 4 AA8 6 VAL B 232 GLU B 237 1 O TYR B 236 N LEU B 168 SHEET 5 AA8 6 LEU B 251 VAL B 259 1 O ILE B 258 N VAL B 235 SHEET 6 AA8 6 SER B 290 GLY B 293 1 O GLN B 292 N VAL B 259 CISPEP 1 PRO A 83 PRO A 84 0 2.68 CISPEP 2 PRO B 83 PRO B 84 0 2.83 CRYST1 46.830 51.410 75.880 93.86 91.48 101.29 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021354 0.004263 0.000869 0.00000 SCALE2 0.000000 0.019835 0.001468 0.00000 SCALE3 0.000000 0.000000 0.013219 0.00000